Insider · CIK 0001209114

QUINLAN KEVIN W

Reports to the SEC for 2 companies · BEDFORD, MA

sec.gov

Transactions

Companies

Filings

CIK

0001209114

Forms 4 and 5

Insider transactions

29 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2013-03-27	ANIKAnika Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+18.4K sh	$11.24	+$207K	45,486
2013-03-27	ANIKAnika Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−18.4K sh	$11.24	−$207K	27,112
2013-03-22	ANIKAnika Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+11.6K sh	$11.24	+$131K	38,740
2013-03-22	ANIKAnika Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−11.6K sh	$11.24	−$131K	27,112
2013-03-22	ANIKAnika Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+20K sh	$11.24	+$225K	47,110
2013-03-22	ANIKAnika Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−20K sh	$11.24	−$225K	27,112
2013-03-21	ANIKAnika Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+25K sh	$11.24	+$281K	52,112
2013-03-21	ANIKAnika Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−25K sh	$11.24	−$281K	27,112
2013-02-27	ANIKAnika Therapeutics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+5,000 sh	$6.99	+$35K	20,744
2013-02-27	ANIKAnika Therapeutics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+6,368 sh	$6.99	+$44.5K	27,112
2012-03-01	ANIKAnika Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+37.5K sh	—	—	37,500
2011-01-18	ANIKAnika Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+30K sh	—	—	30,000
2010-08-23	ANIKAnika Therapeutics, Inc.P Purchase	Chief Financial Officer	PPurchase	+4,000 sh	$5.00	+$20K	15,744
2010-01-26	ANIKAnika Therapeutics, Inc. · Stock Appreciation RightsA Award	Chief Financial Officer	AAward	+25K sh	—	—	25,000
2009-03-27	ANIKAnika Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+6,744 sh	—	—	11,744
2009-03-02	ANIKAnika Therapeutics, Inc. · Stock Appreciation RightsA Award	Chief Financial Officer	AAward	+30K sh	$3.05	+$91.5K	30,000
2008-01-31	ANIKAnika Therapeutics, Inc. · Stock Appreciation RightsA Award	Chief Financial Officer	AAward	+20.6K sh	—	—	20,570
2005-07-11	ANIKAnika Therapeutics, Inc. · Stock Option (Right to Purchase)A Award	Chief Financial Officer	AAward	+75K sh	$11.24	+$843K	75,000
2005-02-11	PRESSURE BIOSCIENCES INCM Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$3.25	+$16.3K	36,744
2005-02-11	PRESSURE BIOSCIENCES INCM Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$3.25	+$32.5K	46,744
2005-02-11	PRESSURE BIOSCIENCES INCM Exercise/Conversion	Director	MExercise/Conversion	+24K sh	$2.60	+$62.4K	70,744
2005-02-11	PRESSURE BIOSCIENCES INCM Exercise/Conversion	Director	MExercise/Conversion	+42K sh	$3.08	+$129K	112,744
2005-02-11	PRESSURE BIOSCIENCES INCM Exercise/Conversion	Director	MExercise/Conversion	+55K sh	$2.70	+$149K	167,744
2005-02-11	PRESSURE BIOSCIENCES INCD Disposition to Issuer	Director	DDisposition to Issuer	−165K sh	$3.50	−$578K	2,500
2005-02-11	PRESSURE BIOSCIENCES INCOption (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,000 sh	—	—	0
2005-02-11	PRESSURE BIOSCIENCES INCOption (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	0
2005-02-11	PRESSURE BIOSCIENCES INCOption (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−24K sh	—	—	0
2005-02-11	PRESSURE BIOSCIENCES INCOption (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−42K sh	—	—	10,000
2005-02-11	PRESSURE BIOSCIENCES INCOption (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−55K sh	—	—	0

Recent filings

Accepted (ET)
Apr 24
QUINLAN KEVIN W0001140361-13-015029
SEC(opens sec.gov)
Mar 254
QUINLAN KEVIN W0001140361-13-013922
SEC(opens sec.gov)
Mar 44
QUINLAN KEVIN W0001140361-13-010486
SEC(opens sec.gov)
Mar 84
QUINLAN KEVIN W0001140361-12-014284
SEC(opens sec.gov)
Jan 204
QUINLAN KEVIN W0001140361-11-003522
SEC(opens sec.gov)
Aug 244
QUINLAN KEVIN W0001140361-10-034761
SEC(opens sec.gov)
Jan 284
QUINLAN KEVIN W0001140361-10-002976
SEC(opens sec.gov)
Mar 304
QUINLAN KEVIN W0001104659-09-021366
SEC(opens sec.gov)
Mar 34
QUINLAN KEVIN W0001104659-09-013950
SEC(opens sec.gov)
Feb 44
QUINLAN KEVIN W0001104659-08-006980
SEC(opens sec.gov)
Jul 134
ANIKA THERAPEUTICS INC0001209114-05-000003
SEC(opens sec.gov)
Feb 154
QUINLAN KEVIN W0001104659-05-006844
SEC(opens sec.gov)

Companies

Address

32 WIGGINS AVE.

BEDFORD, MA, 01730